Literature DB >> 34247230

Efficacy of baricitinib for refractory large-vessel vasculitis.

Alexis Régent1,2, Benjamin Terrier1,2, Paul Legendre1,2, Myriam Wartski3, Pascal Cohen1,2, Luc Mouthon1,2, Claire Le Jeunne1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34247230     DOI： 10.1093/rheumatology/keab541

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

Review 1.  Treatment of Giant Cell Arteritis (GCA).

Authors:  Alexis Régent; Luc Mouthon
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

Review 2.  Perspectives of JAK Inhibitors for Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Motomu Hashimoto
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

Review 3.  Advances in the Treatment of Giant Cell Arteritis.

Authors:  Santos Castañeda; Diana Prieto-Peña; Esther F Vicente-Rabaneda; Ana Triguero-Martínez; Emilia Roy-Vallejo; Belén Atienza-Mateo; Ricardo Blanco; Miguel A González-Gay
Journal:  J Clin Med       Date:  2022-03-13       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.